Outrage as ovarian cancer patients are denied revolutionary drug

Commenting on the decision not to prescribe olaparib on the NHS, Professor Jonathan Ledermann (UCL CRUK Cancer Trials Centre) described the verdict as 'devastating'. Read: Daily Mail